BioMarin Pharmaceutical, Inc. (BMRN)

58.13 +0.98 (+1.71%) USD  |  NASDAQ  |  Feb 06, 16:00
58.45 +0.32 (+0.55%) Pre-Market: 09:24
More

BioMarin Pharmaceutical EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Merck & Co., Inc. Upgrade
Gilead Sciences, Inc. Upgrade
AbbVie, Inc. Upgrade
Amgen, Inc. Upgrade